Genetics of Atrial Fibrillation

Cardiology Clinics

Volumn 27, Issue 1, 2009, Pages 25-33

  Lubitz, Steven A ^a,b   Yi, B Alexander ^c   Ellinor, Patrick T ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Arrhythmia; Atrial fibrillation; Gene; Genetics; Mutation

Indexed keywords

GLYCINE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KV1.5; SERINE;

CHROMOSOME 4; CHROMOSOME VARIANT; FAMILIAL DISEASE; FRAMESHIFT MUTATION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; HEART ATRIUM FIBRILLATION; HUMAN; LINKAGE ANALYSIS; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ATRIAL FIBRILLATION; DNA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ION CHANNELS; LINKAGE (GENETICS); MUTATION;

EID: 57849110465     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2008.09.007     Document Type: Review

References (68)

1. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114 2 (2006) 119-125
2. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285 18 (2001) 2370-2375
3. Coyne K.S., Paramore C., Grandy S., et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 9 5 (2006) 348-356
4. Benjamin E.J., Wolf P.A., D'Agostino R.B., et al. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation 98 10 (1998) 946-952
5. Gajewski J., and Singer R.B. Mortality in an insured population with atrial fibrillation. JAMA 245 15 (1981) 1540-1544
6. Arnar D.O., Thorvaldsson S., Manolio T.A., et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 27 6 (2006) 708-712
7. Ellinor P.T., Yoerger D.M., Ruskin J.N., et al. Familial aggregation in lone atrial fibrillation. Hum Genet 118 2 (2005) 179-184
8. Fox C.S., Parise H., D'Agostino Sr. R.B., et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 291 23 (2004) 2851-2855
9. Darbar D., Herron K.J., Ballew J.D., et al. Familial atrial fibrillation is a genetically heterogeneous disorder. [comment]. J Am Coll Cardiol 41 12 (2003) 2185-2192
10. Chen Y.H., Xu S.J., Bendahhou S., et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 299 5604 (2003) 251-254
11. Yang Y., Xia M., Jin Q., et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 75 5 (2004) 899-905
12. Xia M., Jin Q., Bendahhou S., et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 332 4 (2005) 1012-1019
13. Olson T.M., Alekseev A.E., Liu X.K., et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 15 14 (2006) 2185-2191
14. Otway R., Vandenberg J.I., Guo G., et al. Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation?. J Am Coll Cardiol 49 5 (2007) 578-586
15. Chen L.Y., Ballew J.D., Herron K.J., et al. A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther 81 1 (2007) 35-41
16. Darbar D., Kannankeril P.J., Donahue B.S., et al. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 117 15 (2008) 1927-1935
17. Ellinor P.T., Nam E.G., Shea M.A., et al. Cardiac sodium channel mutation in atrial fibrillation. J Neurosci 5 1 (2008) 99-105
18. Ellinor P.T., Moore R.K., Patton K.K., et al. Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart 90 12 (2004) 1487-1488
19. Ellinor P.T., Petrov-Kondratov V.I., Zakharova E., et al. Potassium channel gene mutations rarely cause atrial fibrillation. BMC Med Genet 7 (2006) 70
20. Wolff L. Familial auricular fibrillation. N Engl J Med 229 (1943) 396-398
21. Consortium T.I.H. A haplotype map of the human genome. Nature 437 7063 (2005) 1299-1320
22. Brugada R., Tapscott T., Czernuszewicz G.Z., et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 336 13 (1997) 905-911
23. Ellinor P.T., Shin J.T., Moore R.K., et al. Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation 107 23 (2003) 2880-2883
24. Oberti C., Wang L., Li L., et al. Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy. Circulation 110 25 (2004) 3753-3759
25. Volders P.G., Zhu Q., Timmermans C., et al. Mapping a novel locus for familial atrial fibrillation on chromosome 10p11-q21. Heart Rhythm 4 4 (2007) 469-475
26. Hodgson-Zingman D.M., Karst M.L., Zingman L.V., et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 359 2 (2008) 158-165
27. Schenzer A., Friedrich T., Pusch M., et al. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. J Neurosci 25 20 (2005) 5051-5060
28. Bellocq C., van Ginneken A.C.G., Bezzina C.R., et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109 (2004) 2394-2397
29. Hong K., Piper D.R., Diaz-Valdecantos A., et al. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 68 3 (2005) 433-440
30. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 415 6868 (2002) 219-226
31. Hagendorff A., Schumacher B., Kirchhoff S., et al. Conduction disturbances and increased atrial vulnerability in connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 99 (1999) 1508-1515
32. Gollob M.H., Jones D.L., Krahn A.D., et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 354 25 (2006) 2677-2688
33. Tsai C.T., Lai L.P., Lin J.L., et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109 13 (2004) 1640-1646
34. Bedi M., McNamara D., London B., et al. Genetic susceptibility to atrial fibrillation in patients with congestive heart failure. Heart Rhythm 3 7 (2006) 808-812
35. Yamashita T., Hayami N., Ajiki K., et al. Is ACE gene polymorphism associated with lone atrial fibrillation?. Jpn Heart J 38 5 (1997) 637-641
36. Fatini C., Sticchi E., Gensini F., et al. Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility. Int J Cardiol 120 1 (2007) 59-65
37. Ravn L.S., Benn M., Nordestgaard B.G., et al. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population. Pharmacogenet Genomics 18 6 (2008) 525-533
38. Tsai C.T., Hwang J.J., Chiang F.T., et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation: a regression approach for the detection of gene-gene interactions in a large hospitalized population. Cardiology 111 1 (2008) 1-7
39. Nagai T., Ogimoto A., Okayama H., et al. A985G polymorphism of the endothelin-2 gene and atrial fibrillation in patients with hypertrophic cardiomyopathy. Circ J 71 12 (2007) 1932-1936
40. Amir O., Amir R.E., Paz H., et al. Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure. Am J Cardiol 102 3 (2008) 326-329
41. Nyberg M.T., Stoevring B., Behr E.R., et al. The variation of the sarcolipin gene (SLN) in atrial fibrillation, long QT syndrome and sudden arrhythmic death syndrome. Clin Chim Acta 375 1-2 (2007) 87-91
42. Asselbergs F.W., Moore J.H., van den Berg M.P., et al. A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study. BMC Med Genet 7 (2006) 39
43. Juang J.M., Chern Y.R., Tsai C.T., et al. The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int J Cardiol 116 1 (2007) 107-112
44. Firouzi M., Ramanna H., Kok B., et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 95 4 (2004) e29-e33
45. Fatini C., Sticchi E., Genuardi M., et al. Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation. Eur Heart J 27 14 (2006) 1712-1718
46. Sinner M.F., Pfeufer A., Akyol M., et al. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur Heart J (2008) 7:907-14
47. Lai L.P., Su M.J., Yeh H.M., et al. Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J 144 3 (2002) 485-490
48. Ravn L.S., Hofman-Bang J., Dixen U., et al. Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillation. Am J Cardiol 96 3 (2005) 405-407
49. Zeng Z., Tan C., Teng S., et al. The single nucleotide polymorphisms of I(Ks) potassium channel genes and their association with atrial fibrillation in a Chinese population. Cardiology 108 2 (2007) 97-103
50. Gaudino M., Andreotti F., Zamparelli R., et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 108 Suppl 1 (2003) II195-II199
51. Kato K., Oguri M., Hibino T., et al. Genetic factors for lone atrial fibrillation. Int J Mol Med 19 6 (2007) 933-939
52. Schreieck J., Dostal S., von Beckerath N., et al. C825T polymorphism of the G-protein beta3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation. Am Heart J 148 3 (2004) 545-550
53. Afzal A.R., Mandal K., Nyamweya S., et al. Association of Met439Thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum HSP70 protein levels. Cardiology 110 1 (2008) 45-52
54. Risch N.J. Searching for genetic determinants in the new millennium. Nature 405 6788 (2000) 847-856
55. Saxena R., Voight B.F., Lyssenko V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 5829 (2007) 1331-1336
56. Frayling T.M., Timpson N.J., Weedon M.N., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 5826 (2007) 889-894
57. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316 5830 (2007) 1488-1491
58. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 5830 (2007) 1491-1493
59. Dewan A., Liu M., Hartman S., et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314 5801 (2006) 989-992
60. Arking D.E., Pfeufer A., Post W., et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38 6 (2006) 644-651
61. Hunter D.J., and Kraft P. Drinking from the fire hose-statistical issues in genomewide association studies. N Engl J Med 357 5 (2007) 436-439
62. Gudbjartsson D.F., Arnar D.O., Helgadottir A., et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448 7151 (2007) 353-357
63. Gage P.J., Suh H., and Camper S.A. Dosage requirement of Pitx2 for development of multiple organs. Development 126 20 (1999) 4643-4651
64. Campione M., Ros M.A., Icardo J.M., et al. Pitx2 expression defines a left cardiac lineage of cells: evidence for atrial and ventricular molecular isomerism in the iv/iv mice. Dev Biol 231 1 (2001) 252-264
65. Franco D., and Campione M. The role of Pitx2 during cardiac development. Linking left-right signaing and congenital heart diseases. Trends Cardiovasc Med 13 (2003) 157-163
66. Logan M., Pagan-Westphal S.M., Smith D.M., et al. The transcription factor Pitx2 mediates situs-specific morphogenesis in response to left-right asymmetric signals. Cell 94 3 (1998) 307-317
67. Mommersteeg M.T., Brown N.A., Prall O.W., et al. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res 101 9 (2007) 902-909
68. Mommersteeg M.T., Hoogaars W.M., Prall O.W., et al. Molecular pathway for the localized formation of the sinoatrial node. Circ Res 100 3 (2007) 354-362